Keep Me Logged In
The M&A activity in the pharmaceutical sector reveals that the industry is planning for the next 15-20 years, and is an opportunity for groups to diversify their tax bases, CNBC's Catherine Boyle explains.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by